Potential of cyclodextrin complexation and liposomes in topical delivery of ketorolac: In vitro and in vivo evaluation

AAPS PharmSciTech

Volumn 9, Issue 4, 2008, Pages 1165-1170

  Nagarsenker, Mangal S ^a   Amin, L ^a   Date, Abhijit A ^a  

^a BOMBAY COLLEGE OF PHARMACY   (India)

Author keywords

Hydroxypropyl cyclodextrin; Ketorolac acid; Ketorolac tromethamine; Liposomes; Transdermal delivery

Indexed keywords

2 HYDROXYPROPYL BETA CYCLODEXTRIN; CARRAGEENAN; KETOROLAC; KETOROLAC TROMETAMOL; LIPOSOME; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN; BETA CYCLODEXTRIN DERIVATIVE; DRUG CARRIER; NONSTEROID ANTIINFLAMMATORY AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG FORMULATION; DRUG PENETRATION; GUINEA PIG; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PARTICLE SIZE; PAW EDEMA; SKIN PERMEABILITY; TRANSDERMAL DRUG ADMINISTRATION; ANIMAL; BIOAVAILABILITY; CHEMISTRY; HAMSTER; SKIN ABSORPTION; TOPICAL DRUG ADMINISTRATION; ULTRAVIOLET SPECTROPHOTOMETRY;

ADMINISTRATION, TOPICAL; ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BETA-CYCLODEXTRINS; BIOLOGICAL AVAILABILITY; CRICETINAE; DRUG CARRIERS; KETOROLAC; LIPOSOMES; SKIN ABSORPTION; SPECTROPHOTOMETRY, ULTRAVIOLET;

EID: 63649131873     PISSN: None     EISSN: 15309932     Source Type: Journal    
DOI: 10.1208/s12249-008-9157-2     Document Type: Article

References (16)

1. M.M. Buckley, and R.N. Brogden. Ketorolac: A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential. Drugs. 39:86-109 (1990).
2. J.R. DeAndrade, M. Maslanka, T. Maneatis, L. Bynum, and M. Burchmore. The use of ketorolac in the management of postoperative pain. Orthopedics. 17:157-166 (1994).
3. J.C. Gillis, and R.N. Brogden. Ketorolac: A reappraisal of its pharmacodynamic and pharmacokinetic properties and therapeutic use in pain management. Drugs. 53:139-188 (1997).
4. D.I. Reinhart. Minimizing the adverse effects of ketorolac. Drug Safety. 22:487-497 (2000).
5. Y.A. Cho, and H.S. Gwak. Transdermal delivery of ketorolac tromethamine: effects of vehicles and penetration enhancers. Drug Dev. Ind. Pharm. 30:557-564 (2004).
6. I.A. Alsarra, A.A. Bosela, S.M. Ahmed, and G.M. Mahrous. Proniosomes as a drug carrier for transdermal delivery of ketorolac. Eur. J. Pharm. Biopharm. 59:485-490 (2005).
7. B.Y. Kim, H.J. Doh, T.N. Le, W.J. Cho, C.S. Yong, H.G. Choi, J.S. Kim, C.H. Lee, and D.D. Kim. Ketorolac amide prodrugs for transdermal delivery: Stability and in vitro rat skin permeation studies. Int. J. Pharm. 293:193-202 (2005).
8. K. Park, D. Verotta, S.K. Gupta, and L.B. Sheiner. Passive versus electrotransport-faciliated transdermal absorption of ketorolac. Clin. Pharmacol. Ther. 63:303-315 (1998).
9. S.B. Tiwari, and N. Udupa. Investigation into the potential of iontophoresis facilitated delivery of ketorolac. Int. J. Pharm. 260:93-103 (2003).
10. S.B. Tiwari, and R.M. Pai. Influence of ultrasound on the percutaneous absorption of ketorolac tromethamine in vitro across rat skin. Drug Deliv. 11:47-51 (2004).
11. M. Masson, T. Loftsson, G. Masson, and E. Stefansson. Cyclodextrins as permeation enhancers: Some theoretical evaluations and in vitro testing. J. Control. Rel. 59:107-118 (1999).
12. T. Loftsson, and M. Masson. Cyclodextrins in topical drug formulations: theory and practice. Int. J. Pharm. 225:15-30 (2001).
13. M.M.A. Elsayed, O.Y. Abdallah, V.F. Naggar, and N.M. Khalafallah. Lipid vesicles for skin delivery of drugs: Reviewing three decades of research. Int. J. Pharm. 332:1-16 (2007).
14. M.S. Nagarsenker, R.N. Meshram, and G. Ramprakash. Solid dispersion of hydroxypropyl β-cyclodextrin and ketorolac: Enhancement of in-vitro dissolution rates, improvement in anti-inflammatory activity and reduction in ulcerogenicity in rats. J. Pharm. Pharmacol. 52:949-956 (2000).
15. C.A. Ventura, S. Tommasini, A. Falcone, I. Giannone, D. Paolino, V. Sdrafkakis, M.R. Mondello, and G. Puglisi. Influence of modified cyclodextrins on solubility and percutaneous absorption of celecoxib through human skin. Int. J. Pharm. 314:37-45 (2006).
16. F. Maestrelli, M.L. Gonzalez-Rodriguez, A.M. Rabasco, and P. Mura. Preparation and characterisation of liposomes encapsulating ketoprofen-cyclodextrin complexes for transdermal drug delivery. Int. J. Pharm. 298:55-67 (2005).